Skip to main content
SpringerLink
Log in

Silencing prostate cancer

  • News & Views
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Systemic delivery of an siRNA–aptamer chimera leads to prostate cancer regression in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Strategies for systemic delivery of siRNA.

References

  1. Whitehead, K.A., Langer, R. & Anderson, D.G. Nat. Rev. Drug Discov. 8, 129–138 (2009).

    Article  CAS  Google Scholar 

  2. Dassie, J.P. et al. Nat Biotechnol. 27, 839–846 (2009).

    Article  CAS  Google Scholar 

  3. McNamara, J.O. et al. Nat. Biotechnol. 24, 1005–1015 (2006).

    Article  CAS  Google Scholar 

  4. Zimmermann, T.S. et al. Nature 441, 111–114 (2006).

    Article  CAS  Google Scholar 

  5. Akinc, A. et al. Nat. Biotechnol. 26, 561–569 (2008).

    Article  CAS  Google Scholar 

  6. Frank-Kamenetsky, M. et al. Proc. Natl. Acad. Sci. USA 105, 11915–11920 (2008).

    Article  CAS  Google Scholar 

  7. Judge, A.D. et al. J. Clin. Invest. 119, 661–673 (2009).

    Article  CAS  Google Scholar 

  8. Peer, D. et al. Science 319, 627–630 (2008).

    Article  CAS  Google Scholar 

  9. Rozema, D.B. et al. Proc. Natl. Acad. Sci. USA 104, 12982–12987 (2007).

    Article  CAS  Google Scholar 

  10. Hu-Lieskovan, S. et al. Cancer Res 65, 8984–8992 (2005).

    Article  CAS  Google Scholar 

  11. Soutschek, J. et al. Nature 432, 173–178 (2004).

    Article  CAS  Google Scholar 

  12. Chu, T.C., Twu, K.Y., Ellington, A.D. & Levy, M. Nucleic Acids Res. 34, e73 (2006).

    Article  Google Scholar 

  13. Zhou, J. et al. Mol. Ther. 16, 1481–1489 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ivanka Toudjarska and Antonin de Fougerolles are at Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.,

    Ivanka Toudjarska & Antonin de Fougerolles

Authors
  1. Ivanka Toudjarska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonin de Fougerolles
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonin de Fougerolles.

Ethics declarations

Competing interests

A.D.F. and I.T. are employees of Alnylam Pharmaceuticals, a company engaged in the development of RNAi therapeutics.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toudjarska, I., de Fougerolles, A. Silencing prostate cancer. Nat Biotechnol 27, 821–823 (2009). https://doi.org/10.1038/nbt0909-821

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0909-821

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation